Semaglutide is part of a group of medicines called GLP-1 receptor agonists, commonly used to manage type 2 diabetes. In recent years, it has also gained worldwide attention for helping with weight ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET In this video The patent on semaglutide, found in Novo Nordisk's Ozempic and Wegovy weight-loss drugs, expired in India on March 20. Vikrant ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

New Delhi: Strides Pharma Science on Tuesday said it has inked a pact with Sandoz AG to acquire certain branded generic products across Sub-Saharan Africa. Strides Pharma International AG (SPIAG) has ...

WASHINGTON, DC (Reuters) – President Donald Trump announced plans to impose a 25% or higher tariff on semiconductor and pharmaceutical imports, a move that could significantly impact India’s ...